CETP Inhibition: Past Failures and Future Hopes

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Why past failures must inform future approaches

ion: Encounters and Avoidance,” at www.ias.edu/ideas/2016/bois-picasso. T H E B A R N E S FO U N D A T IO N A R C H IV E S M A T IS SE , P A R IS Matisse in the Barnes Foundation The hand-to-hand combat between the artist and fifty-two square meters of surface G16-24022_Newsletteril_Spring2016_FINAL.qxp_Layout 1 4/29/16 10:35 AM Page 12

متن کامل

Mizaj past, present and future

Temperament (Mizaj), as an individual factor, has great importance in traditional medicine and its use in diagnosis and treatment of diseases, as well as the individual lifestyle is very common. Since medicine moves toward Personalized Medicine, the root of individual differences will find its position in different aspects of medicine in early future. In traditional medicine, temperament is ...

متن کامل

Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes

Infection with human immunodeficiency virus (HIV) remains a global public health concern and is particularly serious in low- and middle-income countries. Widespread sexual violence and poverty, among other factors, increase the risk of infection in women, while currently available prevention methods are outside the control of most. This has driven the study of vaginal microbicides to prevent se...

متن کامل

Tuberculosis: Past, Present and Future

  Background Tuberculosis (TB) is the second-most common cause of death from infectious disease (after those due to HIV/AIDS). Roughly one-third of the world's population has been infected with M. tuberculosis, with new infections occurring in about 1% of the population each year. People with active TB can infect 10-15 other people through close contact over the course of a year. Materials and ...

متن کامل

Neuroprotective agents in ischemic stroke: past failures and future opportunities

Tissue plasminogen activator is the only US FDA-approved therapy for acute ischemic stroke treatment. There is a need for other therapies such as neuroprotective agents that can be used in acute ischemic stroke patients. Many neuroprotective agents have been shown to be promising after testing in animal models of acute stroke, but when tested in patients, efficacy signals are not consistent or ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Clinical Medicine Insights: Cardiology

سال: 2016

ISSN: 1179-5468,1179-5468

DOI: 10.4137/cmc.s32667